Author(s): Bhushan S. Mahajan, Bhupendra Sing P. Mahale, Amol R. Pawar, Vikas V. Patil, Pankaj S. Patil, Jayesh Songire

Email(s): Email ID Not Available

DOI: 10.52711/2349-2988.2024.00020   

Address: Bhushan S. Mahajan1*, Bhupendra Sing P. Mahale1, Amol R. Pawar1,2*, Vikas V. Patil1, Pankaj S. Patil1, Jayesh Songire1
1Department of Quality Assurance, Kisan Vidya Prasarak Sanstha, Institute of Pharmaceutical Education, Boradi 425428.
2Research Scholar, Sankalchand Patel University, Visnagar – 384315 Gujarat.
*Corresponding Author

Published In:   Volume - 16,      Issue - 2,     Year - 2024


ABSTRACT:
This abstract provides a concise overview of the applications, benefits, and challenges of artificial intelligence (AI) in the pharmaceutical industry. AI technologies are revolutionizing drug discovery, clinical trials, personalized medicine, drug manufacturing, and more. While AI offers advantages such as error minimization, assistance in complex tasks, and continuous operation, challenges including the need for extensive training data and high costs must be addressed. Despite these limitations, AI holds significant promise in transforming the pharmaceutical landscape, enhancing efficiency, and improving patient outcomes.


Cite this article:
Bhushan S. Mahajan, Bhupendra Sing P. Mahale, Amol R. Pawar, Vikas V. Patil, Pankaj S. Patil, Jayesh Songire. A Review on Artificial Intelligence in Pharmacy. Research Journal of Science and Technology. 2024; 16(2):129-6. doi: 10.52711/2349-2988.2024.00020

Cite(Electronic):
Bhushan S. Mahajan, Bhupendra Sing P. Mahale, Amol R. Pawar, Vikas V. Patil, Pankaj S. Patil, Jayesh Songire. A Review on Artificial Intelligence in Pharmacy. Research Journal of Science and Technology. 2024; 16(2):129-6. doi: 10.52711/2349-2988.2024.00020   Available on: https://rjstonline.com/AbstractView.aspx?PID=2024-16-2-5


REFERENCES:
1.    Mak K.-K. And M.R. Pichika, Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019; 24(3): 773-780.
2.    Das, S., R. Dey, and A.K. Nayak, Artificial Intelligence in Pharmacy. Indian Journal of Pharmaceutical Education and Research. 2021; 55(2): 304-318.
3.    Russell, S., D. Dewey, and M. Tegmark, Research priorities for robust and beneficial artificial intelligence: an open letter. AI Magazine, 2015; 36(4).
4.    Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021; 26: 80.
5.    Fleming N. How artificial intelligence is changing drug discovery. Nature. 2018; 557: S55.
6.    Moingeon P, Kuenemann M, Guedj M. Artificial intelligence enhanced drug design and development: Toward a computational precision medicine. Drug Discov Today. 2021; 27:215-22
7.    Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discover. 2011; 10(7):507–19.
8.    Vincent F, Nueda A, Lee J, Schenone M, Prunotto M, Mercola M. Publisher
9.    Correction: phenotypic drug discovery: recent successes, lessons learned and
10.    New Directions. Nat Rev Drug Discov. 2022; 21(7):541.
11.    Li YH, Li XX, Hong JJ, Wang YX, Fu JB, Yang H, et al. Clinical trials, progression speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs. Brief Bioinform. 2020; 21(2):649–62.
12.    Hopkins AL. Network Pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008; 4(11):682–90.
13.    How Artificial Intelligence is Revolutionizing Drug Discovery. [Internet] 2023 [Cited 2023 June 7] Available from: https://blog.petrieflom.law.harvard.edu/2023/03/2 0/how-artificial-intelligence-is-revolutionizing-drug-discovery/
14.    Yang X, Wang Y, Byrne R, Schneider G, Yang S. Concepts of artificial intelligence for computer-assisted drug discovery. Chem Rev. 2019; 119: 10520-94.
15.    Nelson SD, Walsh CG, Olsen CA, McLaughlin AJ, LeGrand JR, Schutz N, et al. Demystifying artificial intelligence in pharmacy. Am J Health Syst Pharm. 2020; 77:1556-70.
16.    Piroozmand F, Mohammadipanah F, Sajedi H. Spectrum of deep learning algorithms in drug discovery. Chem Biol Drug Des. 2020; 96(3):886-901.
17.    Specht DF. IEEE Int Conf Neur Netk 1988; 1:525-32.
18.    Bain EE, Shafner L, Walling DP, Othman AA, Chuang-Stein C, Hinkle J, et al. Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects with Schizophrenia. JMIR Publications. 2017; 5(2):1-14.
19.    Deliberato RO, Celi LA, Stone DJ. Clinical Note Creation, Binning, and Artificial Intelligence. JMIR Publications. 2017; 5(3):1-11
20.    Harrer, S.; Shah, P.; Antony, B.; Hu, J. Artificial Intelligence for Clinical Trial Design. Trends Pharmacol. Sci. 2019, 40, 577–591.
21.    Kolluri, S.; Lin, J.; Liu, R.; Zhang, Y.; Zhang, W. Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: A Review. AAPSJ. 2022, 24, 19.
22.    Li, M.; Liu, R.; Lin, J.; Bunn, V.; Zhao, H. Bayesian Semi-Parametric Design (BSD) for adaptive dose-finding with multiple strata. J. Biopharm. Stat. 2020, 30, 806–820.
23.    Liu, R.; Lin, J.; Li, P. Design considerations for phase I/II dose finding clinical trials in Immuno-oncology and cell therapy. Contemp. Clin. Trials 2020; 96: 106083.  
24.    Zhong F, Xing J, Li X, Liu X, Fu Z, Xiong Z, et al. Artificial intelligence in drug design. Science China Life Science. 2018; 61(10): 1191-204.
25.    Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nature Medicine. 2017; 23(4): 405-8.
26.    Lotfi Shahreza M, Ghadiri N, Mousavi SR, Varshosaz J, Green JR. A review of network-based approaches to drug repositioning. Brief Bioinform. 2018; 19(5): 878-92.
27.    Ramesh, A.N.; Kambhampati, C.; Monson, J.R.; Drew, P.J. Artificial intelligence in medicine. Ann. R. Coll. Surg. Engl. 2004; 86: 334.
28.    Albu, A.; Ungureanu, L. Artificial neural network in medicine. Telemed. J. e-Health. 2012; 18: 446–453.
29.    Jain, A.; Mao, J.; Mohiuddin, K. Artificial neural networks: A tutorial. Computer. 1996;  29: 31–44.
30.    Hopfield, J.J. Artificial neural networks. IEEE Circuits Syst. Mag. 1988; 4: 3–10.
31.    Mak KK, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019; 24(3): 773-780.
32.    Woodcock, J., and Woosley, R. The FDA critical path initiative and its influence on new drug development. Annu. Rev. Med. 2008; 59: 1-12.
33.    Kit-kay M and Mallikarjuna Rao P. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019: 24(3): 773-780.
34.    Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021; 26(1): 80–93
35.    Colombo S. Applications of artificial intelligence in drug delivery and pharmaceutical development. In: Artificial Intelligence in Healthcare. 2020; pp 85–116
36.    Jacob M, Magerko B. Viewpoints AI. In: Proceedings of the 2015
37.    ACM SIGCHI Conference on Creativity and Cognition, pp 361–362
38.    Deep Genomics. Programming RNA Therapies Any Gene, Any Genetic Condition. [cited 2022 13 June]; Available from: https://www.deepgenomics.com/
39.    Shampo, M.A. and R.A. Kyle, J. Craig Venter-The Human Genome Project. Mayo Clinic Proceedings. 2011; 86(4): e26-e27.
40.    Holford, N., Ma, S. C., & Ploeger, B. A. Clinical trial simulation: a review. Clinical pharmacology and therapeutics. 2010; 88(2): 166–182.
41.    Pareek V, Sharma L, Kumar S, Sharma V. Need for Artificial Intelligence in Pharmaceutical Industry and its Limitations. Journal of the Indian Academy of Geriatrics. 2022; 18(14): 217-20.
42.    Jiang F, Jiang Y, Zhi H. Artificial intelligence in healthcare: Past, present and future. Stroke Vasc Neurol. 2017; 2(4): 230-43.
43.    Manikiran SS, Prasanthi NL. Artificial Intelligence: Milestones and Role in Pharma and Healthcare Sector. Pharma Times. 2019; 51(1): 10-1.
44.    Silver D, Schrittwieser J, Simonyan K. Mastering the game of Go without human knowledge. Nature. 2017; 550(7676): 354-9.


Recomonded Articles:

Author(s): Ganesh Shinde, Godage R. K, Dr R. S. Jadhav, Barhate Manoj, Bhagwat Aniket

DOI: 10.5958/2349-2988.2020.00005.4         Access: Open Access Read More

Author(s): Rutuja S Nalkar, Suhas S Siddheshwar, Mahesh H Kolhe

DOI: 10.52711/2349-2988.2021.00036         Access: Open Access Read More

Author(s): Premjit S Nannaware, Suhas S. Siddheshwar, M.H. Kolhe

DOI: 10.52711/2349-2988.2021.00019         Access: Open Access Read More

Author(s): Anuja Uddhav Deokar, Dr Suhas Siddheshwar, Sudarshan. B. Kakad

DOI: 10.5958/2349-2988.2020.00004.2         Access: Open Access Read More

Author(s): Debjit Bhowmik, K.P. Sampath Kumar, Lokesh Deb

DOI: 10.5958/2349-2988.2016.00012.7         Access: Closed Access Read More

Author(s): RS Jadhav, PN Kendre, MH Kolhe, S N Lateef, SM Shelke, RK Godge

DOI:         Access: Open Access Read More

Author(s): Rupali Tambe, Someshwar Mankar, Santosh Dighe

DOI: 10.5958/2349-2988.2020.00003.0         Access: Open Access Read More

Author(s): Nikam Pooja, Baokar Shrikrishna, Undare Santosh, Patil R.N

DOI: 10.5958/2349-2988.2016.00001.2         Access: Open Access Read More

Author(s): Bhushan A. Bhairav, Prajakta A. Kokane, Ravindra B. Saudagar

DOI: 10.5958/2349-2988.2016.00022.X         Access: Closed Access Read More

Author(s): Panchawat S.

DOI:         Access: Open Access Read More

Author(s): Priyanka Pandey, Rakesh Mehta, Ravi Upadhyay

DOI:         Access: Open Access Read More

Author(s): S. D. Mankar, Anjali Dama, M. S. Bhosale, Dr. S. S. Sidhheshwar

DOI: 10.5958/2349-2988.2020.00011.X         Access: Open Access Read More

Author(s): Hiren M. Marvaniya, Divyesh J. Vanparia, Renu Chauhan, Dhrubo Jyoti Sen

DOI:         Access: Open Access Read More

Research Journal of Science and Technology (RJST) is an international, peer-reviewed journal, devoted to science and technology...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2349-2988 


Recent Articles




Tags